Literature DB >> 18484083

Criteria for validating mouse models of psychiatric diseases.

Kathryn K Chadman1, Mu Yang, Jacqueline N Crawley.   

Abstract

Animal models of human diseases are in widespread use for biomedical research. Mouse models with a mutation in a single gene or multiple genes are excellent research tools for understanding the role of a specific gene in the etiology of a human genetic disease. Ideally, the mouse phenotypes will recapitulate the human phenotypes exactly. However, exact matches are rare, particularly in mouse models of neuropsychiatric disorders. This article summarizes the current strategies for optimizing the validity of a mouse model of a human brain dysfunction. We address the common question raised by molecular geneticists and clinical researchers in psychiatry, "what is a 'good enough' mouse model"? Published 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 18484083      PMCID: PMC2914616          DOI: 10.1002/ajmg.b.30777

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  135 in total

Review 1.  Neural consequences of environmental enrichment.

Authors:  H van Praag; G Kempermann; F H Gage
Journal:  Nat Rev Neurosci       Date:  2000-12       Impact factor: 34.870

Review 2.  List of transgenic and knockout mice: behavioral profiles.

Authors:  V Bolivar; M Cook; L Flaherty
Journal:  Mamm Genome       Date:  2000-04       Impact factor: 2.957

3.  Molecular and neuronal substrate for the selective attenuation of anxiety.

Authors:  K Löw; F Crestani; R Keist; D Benke; I Brünig; J A Benson; J M Fritschy; T Rülicke; H Bluethmann; H Möhler; U Rudolph
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

4.  Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.

Authors:  U Rudolph; F Crestani; D Benke; I Brünig; J A Benson; J M Fritschy; J R Martin; H Bluethmann; H Möhler
Journal:  Nature       Date:  1999-10-21       Impact factor: 49.962

5.  Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.

Authors:  R M McKernan; T W Rosahl; D S Reynolds; C Sur; K A Wafford; J R Atack; S Farrar; J Myers; G Cook; P Ferris; L Garrett; L Bristow; G Marshall; A Macaulay; N Brown; O Howell; K W Moore; R W Carling; L J Street; J L Castro; C I Ragan; G R Dawson; P J Whiting
Journal:  Nat Neurosci       Date:  2000-06       Impact factor: 24.884

6.  Implementation of a large-scale ENU mutagenesis program: towards increasing the mouse mutant resource.

Authors:  P M Nolan; J Peters; L Vizor; M Strivens; R Washbourne; T Hough; C Wells; P Glenister; C Thornton; J Martin; E Fisher; D Rogers; J Hagan; C Reavill; I Gray; J Wood; N Spurr; M Browne; S Rastan; J Hunter; S D Brown
Journal:  Mamm Genome       Date:  2000-07       Impact factor: 2.957

Review 7.  Tests of the mouse visual system.

Authors:  L H Pinto; C Enroth-Cugell
Journal:  Mamm Genome       Date:  2000-07       Impact factor: 2.957

8.  Anxiety-related behaviors in the elevated zero-maze are affected by genetic factors and retinal degeneration.

Authors:  M N Cook; R W Williams; L Flaherty
Journal:  Behav Neurosci       Date:  2001-04       Impact factor: 1.912

9.  Molecular targets for the myorelaxant action of diazepam.

Authors:  F Crestani; K Löw; R Keist; M Mandelli; H Möhler; U Rudolph
Journal:  Mol Pharmacol       Date:  2001-03       Impact factor: 4.436

10.  Chronic social stress reduces dendritic arbors in CA3 of hippocampus and decreases binding to serotonin transporter sites.

Authors:  C R McKittrick; A M Magariños; D C Blanchard; R J Blanchard; B S McEwen; R R Sakai
Journal:  Synapse       Date:  2000-05       Impact factor: 2.562

View more
  41 in total

1.  Social peers rescue autism-relevant sociability deficits in adolescent mice.

Authors:  Mu Yang; Kayla Perry; Michael D Weber; Adam M Katz; Jacqueline N Crawley
Journal:  Autism Res       Date:  2010-10-06       Impact factor: 5.216

Review 2.  Molecular and cellular mechanisms of learning disabilities: a focus on NF1.

Authors:  C Shilyansky; Y S Lee; A J Silva
Journal:  Annu Rev Neurosci       Date:  2010       Impact factor: 12.449

Review 3.  Animal models of neuropsychiatric disorders.

Authors:  Eric J Nestler; Steven E Hyman
Journal:  Nat Neurosci       Date:  2010-09-27       Impact factor: 24.884

Review 4.  Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia.

Authors:  Michael J Gandal; J Christopher Edgar; Kerstin Klook; Steven J Siegel
Journal:  Neuropharmacology       Date:  2011-02-22       Impact factor: 5.250

Review 5.  Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disorders.

Authors:  Michael R Hunsaker
Journal:  Prog Neurobiol       Date:  2012-01-13       Impact factor: 11.685

Review 6.  Connecting the CNTNAP2 Networks with Neurodevelopmental Disorders.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2015-02-03

7.  Chronic sleep restriction during development can lead to long-lasting behavioral effects.

Authors:  R Michelle Saré; Merlin Levine; Christine Hildreth; Dante Picchioni; Carolyn Beebe Smith
Journal:  Physiol Behav       Date:  2015-12-19

8.  Towards identification of individual etiologies by resolving genomic and biological conundrums in patients with autism spectrum disorders.

Authors:  M Poot
Journal:  Mol Syndromol       Date:  2013-04-04

9.  Aging leads to prolonged duration of inflammation-induced depression-like behavior caused by Bacillus Calmette-Guérin.

Authors:  Keith W Kelley; Jason C O'Connor; Marcus A Lawson; Robert Dantzer; Sandra L Rodriguez-Zas; Robert H McCusker
Journal:  Brain Behav Immun       Date:  2013-02-26       Impact factor: 7.217

10.  A quantitative analysis of the effects of qualitatively different reinforcers on fixed ratio responding in inbred strains of mice.

Authors:  Blake A Hutsell; M Christopher Newland
Journal:  Neurobiol Learn Mem       Date:  2013-01-26       Impact factor: 2.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.